Your browser doesn't support javascript.
loading
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro.
Roquebert, B; Damond, F; Collin, G; Matheron, S; Peytavin, G; Bénard, A; Campa, P; Chêne, G; Brun-Vézinet, F; Descamps, D.
Affiliation
  • Roquebert B; AP-HP, Groupe hospitalier Bichat-Claude Bernard, Laboratoire de Virologie, Paris F-75018, France.
J Antimicrob Chemother ; 62(5): 914-20, 2008 Nov.
Article in En | MEDLINE | ID: mdl-18718922
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Pyrrolidinones / HIV-2 / Quinolones / Integrase Inhibitors / HIV Integrase / Drug Resistance, Viral Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Antimicrob Chemother Year: 2008 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Pyrrolidinones / HIV-2 / Quinolones / Integrase Inhibitors / HIV Integrase / Drug Resistance, Viral Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Antimicrob Chemother Year: 2008 Document type: Article Affiliation country: Francia Country of publication: Reino Unido